Creating a Risk Score for Prolonged Length of Stay Following Pediatric Lung Transplants

Michael DiLeo1, Ruhi Thapar1, Ashley Montgomery1

  • 1Department of Student Affairs, Baylor College of Medicine, Houston, Texas, USA.

Pediatric Pulmonology
|November 13, 2024
PubMed

Insights

This study identified key factors predicting prolonged length of stay (pLOS) after pediatric lung transplantation (LT). A novel risk score helps stratify patients, enabling targeted interventions to improve outcomes in pediatric LT recipients.

Area of Science:

  • Transplantation research
  • Pediatric surgery
  • Health outcomes analysis

Background:

  • Prolonged length of stay (pLOS) is a significant concern in pediatric lung transplantation (LT), impacting patient outcomes.
  • Limited research exists on predicting pLOS in this specific pediatric population.
  • Identifying predictive factors for pLOS is crucial for optimizing care and resource allocation.

Purpose of the Study:

  • To identify factors associated with pLOS in pediatric LT recipients.
  • To develop a risk score for predicting individual patient risk of pLOS.
  • To inform clinical decision-making and potential interventions.

Main Methods:

  • Analysis of 733 pediatric LT cases from the OPTN database (2000-2022).
  • Utilized LASSO regularization to identify 13 key predictive factors for pLOS.
  • Developed a risk score based on the identified variables and their odds ratios.

Main Results:

  • Recipient ethnicity, need for life support, and age (2-10 years) were associated with increased pLOS.
  • Factors like shorter cold ischemia time, shorter waitlist time, and primary pulmonary hypertension diagnosis were protective.
  • The developed risk score effectively stratified patients into low, medium, and high risk groups for pLOS, with mean LOS of 20.60, 22.53, and 36.72 days, respectively.

Conclusions:

  • A validated model and risk score can identify pediatric LT patients at high risk for pLOS.
  • Early identification allows for targeted interventions on modifiable risk factors before transplantation.
  • This approach can help healthcare systems optimize care and improve outcomes for pediatric LT recipients.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
120
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.0K